News

Resolute Science notified of award of Phase 2 of its $2.1m Fast Track SBIR NIH Grant to Advance the Development of Its Lead Asset RS-5.

We’re delighted to be recognized as one of the fastest, most-exciting biotech startups in Southern California.

A pre-clinical, life science company aiming to develop a safe, effective, and novel therapeutic for the treatment of sol

Resolute Science Awarded Fast Track SBIR NIH Grant to Advance the Development of Its Lead Asset RS-5.